Skip to main content
. 2014 Mar 6;5(5):556–560. doi: 10.1021/ml5000096

Table 1. Screening of Muraymycin Analogues 119 as Anti-Pseudomonas Agents.

    MIC (μg/mL)a
compound MraY IC50 (nM) P. aeruginosa PAO1 P. aeruginosa YY165 (ΔmexB) P. aeruginosa ATCC 25619 P. aeruginosa SR 27156 P. aeruginosa ATCC 27853
1 2.8 >64 64 64 32 >64
2 1.1 >64 >64 >64 >64 >64
3 0.8 >64 >64 >64 >64 >64
4 0.7 >64 >64 >64 >64 >64
5 0.8 >64 >64 >64 >64 >64
6 4.2 >64 >64 >64 >64 >64
7 2.4 >64 32 64 64 >64
8 3.8 64 32 32 32 64
9 2.2 16 8 8 16 32
10 8.5 >64 16 16 64 64
11 2.6 >64 32 32 >64 >64
12 2.7 64 32 32 64 >64
13 29.6 >64 >64 >64 >64 >64
14 6.4 >64 >64 64 >64 >64
15 9.6 >64 >64 64 >64 >64
16 8.1 >64 >64 64 >64 >64
17 13.5 >64 64 64 >64 >64
18 33.1 >64 >64 64 >64 >64
19 105 >64 >64 >64 >64 >64
doripenem n.d. 0.5 0.25 0.063 0.031 0.5
a

MICs were determined by a microdilution broth method as recommended by the CLSI with cation-adjusted Mueller–Hinton broth (CA-MHB). Serial 2-fold dilutions of each compound were made in appropriate broth, and the plates were inoculated with 5 × 104 CFU of each strain in a volume of 0.1 mL. Plates were incubated at 35 °C for 20 h, and then MICs were scored.